中国HIV暴露前预防用药专家共识

2020-11-30 中国感染病相关专家组(统称) 中国艾滋病性病.2020.26(11):1265-1271.

我国大陆地区仍缺乏适合国情的HIV 暴露前预防用药指导方案。亟须出台PrEP 实施指南,对PrEP 医学入选标准、服药时机、药物安全性以及咨询检测方案等相关内容提供规范化的指导,为进一步遏制HIV 在

中文标题:

中国HIV暴露前预防用药专家共识

发布日期:

2020-11-30

简要介绍:

我国大陆地区仍缺乏适合国情的HIV 暴露前预防用药指导方案。亟须出台PrEP 实施指南,对PrEP 医学入选标准、服药时机、药物安全性以及咨询检测方案等相关内容提供规范化的指导,为进一步遏制HIV 在我国HIV 感染高风险人群中的流行做出贡献。在广泛征求国内卫生政策制定者、艾滋病研究领域科学家、艾滋病临床治疗专家及社会组织人员意见和建议后,结合PrEP 最新研究进展,总结我国PrEP 项目实施过程中成功经验,编写了我国PrEP 预防HIV 感染的专家共识,旨在为PrEP 在我国的实施提供指导意见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国HIV暴露前预防用药专家共识_徐俊杰.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9d49c1c0020250cf, title=中国HIV暴露前预防用药专家共识, enTitle=, guiderFrom=中国艾滋病性病.2020.26(11):1265-1271., authorId=0, author=, summary=我国大陆地区仍缺乏适合国情的HIV 暴露前预防用药指导方案。亟须出台PrEP 实施指南,对PrEP 医学入选标准、服药时机、药物安全性以及咨询检测方案等相关内容提供规范化的指导,为进一步遏制HIV 在, cover=https://img.medsci.cn/20201219/1608309939368_2020535.jpg, journalId=0, articlesId=null, associationId=858, associationName=中国感染病相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>我国大陆地区仍缺乏适合国情的HIV 暴露前预防用药指导方案。亟须出台PrEP 实施指南,对PrEP 医学入选标准、服药时机、药物安全性以及咨询检测方案等相关内容提供规范化的指导,为进一步遏制HIV 在我国HIV 感染高风险人群中的流行做出贡献。在广泛征求国内卫生政策制定者、艾滋病研究领域科学家、艾滋病临床治疗专家及社会组织人员意见和建议后,结合PrEP 最新研究进展,总结我国PrEP 项目实施过程中成功经验,编写了我国PrEP 预防HIV 感染的专家共识,旨在为PrEP 在我国的实施提供指导意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=64870, tagName=HIV暴露前预防)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=64870, guiderKeyword=HIV暴露前预防, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5371, appHits=154, showAppHits=0, pcHits=948, showPcHits=5217, likes=6, shares=10, comments=15, approvalStatus=1, publishedTime=Sat Dec 19 01:18:29 CST 2020, publishedTimeString=2020-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 19 00:45:53 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:12:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国HIV暴露前预防用药专家共识_徐俊杰.pdf)])
中国HIV暴露前预防用药专家共识_徐俊杰.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071470, encodeId=48d110e14703c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27f15484175, createdName=ms6000000569533831, createdTime=Thu Nov 18 16:52:15 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070781, encodeId=3a0210e0781a5, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Nov 16 15:00:55 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067278, encodeId=52c3106e278e9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:27 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067277, encodeId=f88a106e27746, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:15 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067276, encodeId=80d4106e276da, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:27:45 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-18 ms6000000569533831

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071470, encodeId=48d110e14703c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27f15484175, createdName=ms6000000569533831, createdTime=Thu Nov 18 16:52:15 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070781, encodeId=3a0210e0781a5, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Nov 16 15:00:55 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067278, encodeId=52c3106e278e9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:27 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067277, encodeId=f88a106e27746, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:15 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067276, encodeId=80d4106e276da, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:27:45 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-16 屋顶瞄爱赏月

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071470, encodeId=48d110e14703c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27f15484175, createdName=ms6000000569533831, createdTime=Thu Nov 18 16:52:15 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070781, encodeId=3a0210e0781a5, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Nov 16 15:00:55 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067278, encodeId=52c3106e278e9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:27 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067277, encodeId=f88a106e27746, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:15 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067276, encodeId=80d4106e276da, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:27:45 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 huihui0728

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071470, encodeId=48d110e14703c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27f15484175, createdName=ms6000000569533831, createdTime=Thu Nov 18 16:52:15 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070781, encodeId=3a0210e0781a5, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Nov 16 15:00:55 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067278, encodeId=52c3106e278e9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:27 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067277, encodeId=f88a106e27746, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:15 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067276, encodeId=80d4106e276da, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:27:45 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 huihui0728

    #肿瘤#学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1071470, encodeId=48d110e14703c, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27f15484175, createdName=ms6000000569533831, createdTime=Thu Nov 18 16:52:15 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070781, encodeId=3a0210e0781a5, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Nov 16 15:00:55 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067278, encodeId=52c3106e278e9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:27 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067277, encodeId=f88a106e27746, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:28:15 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067276, encodeId=80d4106e276da, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Nov 05 13:27:45 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 huihui0728

    学习一下

    0

拓展阅读

2017 加拿大HIV暴露前预防和非职业性暴露后预防指南

国外感染病相关专家组(统称) · 2017-11-27

2018 ASHM临床指南:HIV暴露前预防(更新版)

澳大利亚艾滋病医学会(ASHM,Australasian Society for HIV medicine) · 2018-04-01

2018 SAHM意见书:青少年和年轻成人HIV暴露前预防性用药

青少年健康与医学学会(SAHM,Society for Adolescent Health and Medicine) · 2018-10-05

2018 BHIVA/BASHH指南:HIV暴露前预防疗法

英国性健康和艾滋病协会(BASHH,British Association for Sexual Health and HIV) · 2018-10-01

2019 加拿大指南:HIV暴露前预防以及职业外暴露后预防

国外感染病相关专家组(统称) · 2019-02-21